Ziad Omar/LinkedIn
May 26, 2026, 11:34
Ziad Omar: PTT and aPTT Testing – Reading the Intristic Pathway of Coagulation
Ziad Omar, Medical Laboratory Technician at Palestine Red Crescent Society, shared a post on LinkedIn:
“PTT / aPTT is one of the most important screening tests in coagulation, but its interpretation requires more than reading a number.
In this LabCore Education series, we explored the practical and scientific foundation of PTT / aPTT testing:
- Intrinsic and common pathway assessment
- Citrated plasma sample requirements
- 9:1 blood-to-citrate ratio
- Causes of prolonged PTT / aPTT
- Mixing study interpretation
- Practical mixing technique
- Inhibitors and lupus anticoagulant concepts
- Unfractionated heparin monitoring
- Pre-analytical errors
- PT vs PTT / aPTT comparison
The key takeaway:
A prolonged PTT / aPTT should always be interpreted in context — considering sample quality, medications, clinical history, and the need for further testing.
This series is designed for medical laboratory professionals, students, and healthcare workers who want a clear, practical approach to coagulation testing.”

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies
-
Jul 12, 2026, 06:12Precision in Antithrombotic Therapy at ISTH 2026 – The Lancet Haematology
-
Jul 11, 2026, 23:36Emmanuel J Favaloro: A Fresh Perspective on the Manual Tilt Tube Method for PT and INR Determination
-
Jul 11, 2026, 21:47Michelle Meyer: Working Together to Advance Stroke Prevention in Atrial Fibrillation
-
Jul 11, 2026, 21:44Timos Papagatsias: From Promising Concepts to Clinical Differentiation at ISTH 2026
-
Jul 11, 2026, 21:43Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US